Much debate has focused on the possibility that the Ab response to SARS-CoV-2 may be short-lived, while T cell recognition may be strong, durable, and more common. Mild or asymptomatic infections are very common but are not usually diagnosed, making an assessment of the durability of immunity in this common group challenging. A study was done on an exposed health …
Administering bamlanivimab (formerly LY-CoV555), a monoclonal antibody for COVID-19, along with remdesivir (Veklury) was ineffective for patients hospitalized with COVID-19, a randomized trial found. In a preliminary report of the first TICO trial, hospitalized patients with COVID-19 who received a single infusion of the neutralizing monoclonal antibody LY-CoV555 at a dose of 7000 mg, did not have better clinical outcomes …
Since the first cases of COVID-19 were identified in the United States, we have learned a lot however as with anything else in life, we never stop learning! Many residents in our care contracted the COVID-19 virus and required hospitalization. Some of these residents developed blood clots in the lungs, negatively impacting their recovery. Anticoagulation therapy has become common practice …
To mitigate the spread of the 2019 novel coronavirus (SARS-CoV-2), nursing homes are following the Centers for Medicare and Medicaid Services guidelines and are not allowing communal dining, group activities, and only essential visitors are allowed. A study was conducted on data analysis of nursing home resident weights from a single 240-bed non-profit nursing home located in a suburban area, …
Employment-related exposure to severe acute respiratory syndrome coronavirus (SARS-CoV-2) can endanger not only workers but also their household members. Using pre-pandemic data, the prevalence of Centers for Disease Control Prevention (CDC) risk factors for severe coronavirus disease 2019 (COVID-19) were examined. The researchers then estimated how many adults at increased risk of severe COVID-19 held essential jobs and could not …
Not surprisingly, a recent study found that long-term care facility residents are among the populations at greatest risk of morbidity and mortality due to Coronavirus Disease 2019 (COVID-19). In May 2020, the CDC developed interim infection prevention and control (IPC) recommendations for healthcare personnel to prevent COVID-19, which included specific guidelines for LTCFs and an Infection Prevention and Control Assessment …
The first case of SARS-CoV-2 infection in the United States was reported on January 20, 2020 in the state of Washington and to date, the pandemic has led to more than 240,000 COVID-19 deaths, making the United States by far the most affected country globally. To date, the United States and other countries have mostly relied on community-based intervention measures, …
The Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has developed into a global pandemic with millions of people infected and tens of thousands of lives lost. Identifying effective drugs to treat COID-19 is important and urgent, especially the approved drugs that can be immediately tested in clinical trials. In a recent study, researchers developed …
The Institute for the Advancement of Senior Care and its leading media brand iAdvance Senior Care are conducting surveys to uncover COVID-19’s current impact on senior care and long-term care facilities in the United States. With over 75,000 members, the Institute for the Advancement of Senior Care is dedicated to fostering continuous innovation and best practices for business and clinical professionals working throughout the continuum of senior …
People who have had COVID-19 may have an increased risk of being diagnosed with a psychiatric disorder such as anxiety or depression. Researchers looked at the medical records of 69 million people in the United States between January 20 and August 1, 2020. The data included 62,000 people who contracted COVID-19 as part of what the authors described as the …
